Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
出版年份 2015 全文链接
标题
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 42, Issue 7, Pages 880-888
出版商
Wiley
发表日期
2015-07-31
DOI
10.1111/apt.13352
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 539 Anti-TNF-Induced Skin Manifestations in IBD Patients: Role for Increased Drug Exposure?
- (2015) Isabelle Cleynen et al. GASTROENTEROLOGY
- Concomitant Use of Azathioprine/6-Mercaptopurine Decreases the Risk of Anti-TNF–Induced Skin Lesions
- (2015) Jae Seung Soh et al. INFLAMMATORY BOWEL DISEASES
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- (2015) G. W. Moran et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis
- (2014) Alessandro Armuzzi et al. INFLAMMATORY BOWEL DISEASES
- Induction of IL-17+ T Cell Trafficking and Development by IFN- : Mechanism and Pathological Relevance in Psoriasis
- (2014) I. Kryczek et al. JOURNAL OF IMMUNOLOGY
- Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents
- (2013) Gionata Fiorino et al. AUTOIMMUNITY REVIEWS
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- (2013) Cornelia Tillack et al. GUT
- Skin Side Effects of Inflammatory Bowel Disease Therapy
- (2013) Joana Torres et al. INFLAMMATORY BOWEL DISEASES
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Paradoxical inflammation induced by anti-TNF agents in patients with IBD
- (2012) Isabelle Cleynen et al. Nature Reviews Gastroenterology & Hepatology
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature
- (2011) G. Cullen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
- (2011) Iván Guerra et al. Journal of Crohns & Colitis
- Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: The Mayo Clinic experience, 1998 to 2010
- (2011) Eugenia Shmidt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
- (2011) Carl A Anderson et al. NATURE GENETICS
- Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy
- (2010) Jean–François Rahier et al. Clinical Gastroenterology and Hepatology
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
- (2010) Andre Franke et al. NATURE GENETICS
- Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
- (2010) Angelique N. Collamer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials
- (2009) G. R. LICHTENSTEIN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab for the treatment of fistulas in patients with Crohn's disease
- (2009) J-F Colombel et al. GUT
- Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
- (2009) S. Brand GUT
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2008) M J Harrison et al. ANNALS OF THE RHEUMATIC DISEASES
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started